All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI

3' education - Sep. 3, 2019 - Danielle Haanschoten - Zwolle, The Netherlands

Educational information

This video was recorded at the ESC in Paris, France, on September 3, 2019.

Faculty

Danielle Haanschoten, MD, Isala Hartcentrum, Zwolle, The Netherlands.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.